MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with O

Oxcarbazepine

Oxcarbazepine 150mg tablets

Compatible

Stability notes for Oxcarbazepine 150mg tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Trileptal 150mg tablets (Novartis Pharmaceuticals UK Ltd) and oxcarbazepine 150mg tablets (Viatris).

Suppliers (8) of Oxcarbazepine 150mg tablets
Oxcarbazepine 150mg tablets (A A H Pharmaceuticals Ltd)
Oxcarbazepine 150mg tablets (Alliance Healthcare (Distribution) Ltd)
Oxcarbazepine 150mg tablets (Medihealth (Northern) Ltd)
Oxcarbazepine 150mg tablets (Sandoz Ltd)
Oxcarbazepine 150mg tablets (Sigma Pharmaceuticals Plc)
Oxcarbazepine 150mg tablets (Viatris UK Healthcare Ltd)
Trileptal 150mg tablets (Novartis Pharmaceuticals UK Ltd)
Trileptal 150mg tablets (Sigma Pharmaceuticals Plc)

Oxcarbazepine 300mg tablets

Compatible

Stability notes for Oxcarbazepine 300mg tablets

No special requirements for storage.

Provenance

Compatiblity recommendation derived from Trileptal 300mg tablets (Novartis Pharmaceuticals UK Ltd).

Suppliers (13) of Oxcarbazepine 300mg tablets
Oxcarbazepine 300mg tablets (A A H Pharmaceuticals Ltd)
Oxcarbazepine 300mg tablets (Alliance Healthcare (Distribution) Ltd)
Oxcarbazepine 300mg tablets (Crescent Pharma Ltd)
Oxcarbazepine 300mg tablets (Medihealth (Northern) Ltd)
Oxcarbazepine 300mg tablets (Morningside Healthcare Ltd)
Oxcarbazepine 300mg tablets (Sandoz Ltd)
Oxcarbazepine 300mg tablets (Sigma Pharmaceuticals Plc)
Oxcarbazepine 300mg tablets (Viatris UK Healthcare Ltd)
Trileptal 300mg tablets (Abacus Medicine Ltd)
Trileptal 300mg tablets (Lexon (UK) Ltd)
Trileptal 300mg tablets (Novartis Pharmaceuticals UK Ltd)
Trileptal 300mg tablets (Pharmaram Ltd)
Trileptal 300mg tablets (Sigma Pharmaceuticals Plc)

Oxcarbazepine 600mg tablets

Compatible

Stability notes for Oxcarbazepine 600mg tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Trileptal 600mg tablets (Novartis Pharmaceuticals UK Ltd) and oxcarbazepine 600mg tablets (Viatris).

Suppliers (10) of Oxcarbazepine 600mg tablets
Oxcarbazepine 600mg tablets (A A H Pharmaceuticals Ltd)
Oxcarbazepine 600mg tablets (Alliance Healthcare (Distribution) Ltd)
Oxcarbazepine 600mg tablets (Crescent Pharma Ltd)
Oxcarbazepine 600mg tablets (Medihealth (Northern) Ltd)
Oxcarbazepine 600mg tablets (Morningside Healthcare Ltd)
Oxcarbazepine 600mg tablets (Sandoz Ltd)
Oxcarbazepine 600mg tablets (Sigma Pharmaceuticals Plc)
Oxcarbazepine 600mg tablets (Viatris UK Healthcare Ltd)
Trileptal 600mg tablets (Novartis Pharmaceuticals UK Ltd)
Trileptal 600mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.